Skip to main content

Table 2 The clinicopathologic characteristics of NANOG expression in 316 NSCLC patients

From: Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer

   

NANOG(n, %)

 

Variables

case

Low(215)

High(94)

p a

Gender

    

Male

134

90(67.2)

44(32.8)

0.419

Female

175

125(71.4)

50(28.6)

 

Age (years)b

    

<52

149

99(66.4)

50(33.6)

0.248

≥52

160

116(72.5)

44(27.5)

 

Histologic subtype

    

Squamous carcinoma

142

103(72.5)

39(27.5)

0.298

Adenocarcinoma

167

112(67.1)

55(32.9)

 

Histologicalgrade

    

Grade 1

126

105(83.3)

21(16.7)

<0.001

Grade 2

112

80(71.4)

32(28.6)

 

Grade 3

71

30(42.3)

41(57.7)

 

T classification

    

T1

71

50(70.4)

21(29.6)

0.572

T2

58

36(62.1)

22(37.9)

 

T3

126

91(72.2)

35(27.8)

 

T4

54

38(70.4)

16(29.6)

 

Clinical stage

   

0.358

I

108

75(69.4)

33(30.6)

 

II

81

61(75.3)

20(24.7)

 

III

120

79(65.8)

41(34.2)

 
  1. a Chi-square test.
  2. b Patients were divided according to the median values of age.